Dr. Stuart J. Schnitt, M.D.

Dr. Stuart J. Schnitt, M.D. is an internationally recognized expert in breast pathology and currently serves as Chief of Breast Oncologic Pathology at the Dana-Farber Brigham Cancer Center. He is also Associate Director of the Breast Oncology Program at Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Senior Pathologist at Brigham and Women’s Hospital, and Professor of Pathology at Harvard Medical School. Dr. Schnitt has co-led major academic initiatives including the Dana-Farber/Harvard Cancer Center Breast Program and has authored over 340 publications, including the widely used textbook Biopsy Interpretation of the Breast.

Over the course of his career, Dr. Schnitt has played a pivotal role in shaping the field of breast pathology, contributing to the WHO Classification of Tumors of the Breast and training over 35 breast pathology fellows since 1995. His research has significantly advanced the understanding of benign breast disease, breast cancer risk, and local recurrence in breast-conserving therapy. He is a former President of the United States and Canadian Academy of Pathology and continues to be a leading voice in academic pathology worldwide.